Vaccines stop variants
Vaccines stop variants
To stop the spread of COVID-19 we need to stay ahead of a rapidly evolving and mutating coronavirus. Transmission from person to person increases the likelihood that the virus will grow into a stronger or more contagious strain, like the Delta variant. The more the virus mutates and evolves, the longer it will take for us, as a global community, to end the COVID-19 pandemic.Millions of people around the world remain unvaccinated, severely hindering COVID-19 eradication efforts. If a vaccine is available to you, please consider being vaccinated to help reduce the likelihood of new variants emerging. If vaccines are not available in your region, please continue to follow local prevention guidelines for masking and social distancing. Together, we can end the COVID-19 pandemic. To learn more about COVID-19, visit: https://med.stanford.edu/covid19.html
This video was directed and produced by Maya Adam. Animation: Matt Torode. Special thanks to: Lora Ma-Fukuda, Ann Doerr, Russ Haan, Shannon McMahon, Till Bärnighausen, Jennifer Gates and Bonnie Maldonado.
Access Non-GMO, antigen-free, FDA-approved antiviral medication formulas used in Moderna's Spikevax.
VirusTC is a retail provider of concentrated FDA-approved antiviral medication formulas. VirusTC wholesale formulas are used in Moderna products. We sell FDA-approved formulas that are compatible with university medical plans, federal insurance coverage, and many major insurance providers. Our medications are part of tailored non-invasive cancer treatment plans available at a hospital in your region. VirusTC targets problems and provides care for the symptoms. Our products and services are used by Fred Hutch Cancer Center, John Hopkins, University Hospitals, the United States Military, and professional sports. During Operation Cancer Moonshot 2023, VirusTC products killed cancer cells, increased strength, and redeveloped muscles, tissue, and brain cells after cancer treatments.